Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001410578-25-001491
Filing Date
2025-07-24
Accepted
2025-07-24 07:31:02
Documents
88
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 6-K bgm-20250331x6k.htm 6-K 15634
2 EX-99.1 bgm-20250331xex99d1.htm   iXBRL EX-99.1 1613390
3 EX-99.2 bgm-20250331xex99d2.htm EX-99.2 533040
  Complete submission text file 0001410578-25-001491.txt   9228789

Data Files

Seq Description Document Type Size
4 EX-101.SCH bgm-20250331.xsd EX-101.SCH 73347
5 EX-101.CAL bgm-20250331_cal.xml EX-101.CAL 82537
6 EX-101.DEF bgm-20250331_def.xml EX-101.DEF 193457
7 EX-101.LAB bgm-20250331_lab.xml EX-101.LAB 553586
8 EX-101.PRE bgm-20250331_pre.xml EX-101.PRE 418383
91 EXTRACTED XBRL INSTANCE DOCUMENT bgm-20250331xex99d1_htm.xml XML 1774946
Mailing Address NO. 152 HONGLIANG EAST 1ST STREET NO. 1703, TIANFU NEW DISTRICT CHENGDU F4 610200
Business Address NO. 152 HONGLIANG EAST 1ST STREET NO. 1703, TIANFU NEW DISTRICT CHENGDU F4 610200 86-028-64775180
BGM Group Ltd. (Filer) CIK: 0001779578 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 0930
Type: 6-K | Act: 34 | File No.: 001-39805 | Film No.: 251144525
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)